Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2022 Nov 7;35(10):957–961. doi: 10.3967/bes2022.122

Survival Analysis of COVID-19 Patients Based on Different Levels of D-dimer and Coagulation Factors

Abolfazl Zendehdel a, Saeidreza Jamalimoghadamsiahkal b, Maedeh Arshadi c, Forough Godarzi c, Shokouh SHahrousvand c, Hamidreza Hekmat d, Ehsan Sekhavatimoghadam d, Seyedeh Zahra Badrkhahan e, Mina Riahi f, Isa Akbarzadeh c,#, Mohammad Bidkhori c,#
PMCID: PMC9639802  PMID: 36443273

The content is available as a PDF (397.8 KB).

Biography

Biographical note of the first author: Abolfazl Zendehdel, male, born in 1979, Doctor, Associate Professor, faculty member of Tehran University of Medical Sciences, internist.

REFERENCES

  • 1.Soni M, Gopalakrishnan R, Vaishya R, et al. D-dimer level is a useful predictor for mortality in patients with COVID-19: analysis of 483 cases. Diabetes Metab Syndr. 2020;14:2245–2249. doi: 10.1016/j.dsx.2020.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13:1265–1275. doi: 10.1080/17474086.2020.1831383. [DOI] [PubMed] [Google Scholar]
  • 3.Gungor B, Atici A, Baycan OF, et al. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: a systematic review and meta-analysis. Am J Emerg Med. 2021;39:173–179. doi: 10.1016/j.ajem.2020.09.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mihaila RG, Mihaila MD. Coagulation disorders in SARS-CoV-2 infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020;164:226–235. doi: 10.5507/bp.2020.037. [DOI] [PubMed] [Google Scholar]
  • 5.Bauer W, Galtung N, Neuwinger N, et al. A matter of caution: coagulation parameters in COVID-19 do not differ from patients with ruled-out SARS-CoV-2 infection in the emergency department. TH Open. 2021;5:e43–e55. doi: 10.1055/s-0040-1722612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38–44. doi: 10.1016/j.thromres.2016.11.007. [DOI] [PubMed] [Google Scholar]
  • 7.Wong JP, Viswanathan S, Wang M, et al. Current and future developments in the treatment of virus-induced hypercytokinemia. Future Med Chem. 2017;9:169–178. doi: 10.4155/fmc-2016-0181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Zinellu A, Paliogiannis P, Carru C, et al. INR and COVID-19 severity and mortality: a systematic review with meta-analysis and meta-regression. Adv Med Sci. 2021;66:372–380. doi: 10.1016/j.advms.2021.07.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Akama-Garren EH, Li JX. Unbiased identification of clinical characteristics predictive of COVID-19 severity. Clin Exp Med. 2022;22:137–149. doi: 10.1007/s10238-021-00730-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biomedical and Environmental Sciences are provided here courtesy of Elsevier

RESOURCES